Clinical Trial

EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine Treatment

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study plans to learn if certain markers found during electroencephalogram (EEG) analysis could predict fenfluramine responsiveness to give clinicians greater insight into the effectiveness of fenfluramine in people with Lennox Gastaut Syndrome (LGS).
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-08
Trial Details
NCT Number NCT07555171
Lead Sponsor University of Chicago
Collaborators: UCB Pharma
Conditions Lennox Gastaut Syndrome (LGS)
Enrollment 20 participants
Start Date 2026-05-01
Primary Completion 2027-12 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-08-06